Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is KANAMYCIN SULFATE, with a corresponding US DMF Number 28275.
Remarkably, this DMF maintains an Active status since its submission on May 06, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 30, 2016, and payment made on March 08, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II